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Skeletal fractures represent the main negative outcome of most
bone diseases. In fact, in the general population the principal
parameter for judging the efﬁcacy of therapies directed to cor-
rect a bone disease is based on their efﬁcacy in preventing the
occurrence of fractures and the consequent disability, as is the
case of osteoporosis.
It is also well recognized that bone involvement occurs
almost invariably in CKD patients, in particular in the more
advanced stages, and even after renal transplantation this com-
plication remains a main problem. However, although a wealth
of studies are published yearly in the CKD-mineral bone dis-
order (MBD) ﬁeld, only scanty data deal with the risk of frac-
tures in the different stages of CKD and even less with the
efﬁcacy of the therapies used for controlling mineral metabol-
ism (MM) and bone-related parameters on this primary clinical
complication.
This is disappointing, given that most of the few observa-
tional studies published on this topic clearly show that the frac-
ture risk is manifoldly higher in CKD and renal transplant
patients as compared with matched normal subjects [1–4]. A
recent study stressed this concept, showing that the incidence
of fractures progressively increases with the lowering of GFR
from the early stages of CKD [5]. Furthermore, the fracture
risk has been reported to be increased in patients who
experienced an acute kidney injury (AKI) necessitating dialysis,
even when an almost complete recovery of renal function oc-
curs [6].
The shortage of information on this argument is even more
daunting in view of the fact that the occurrence of a fracture
event is associated with a consistently increased risk of death
in both dialysis and renal transplant patients [7–11].
On these considerations, any additional information on this
topic is very welcome.
In this issue ofNephrology Dialysis Transplantation, Hensen
et al. [12], based on data from the Danish Nephrology Registry,
report on the fracture risk of CKD patients whowere on dialysis
on 1 of January 2000 or started dialysis between January 2000
and December 2011 inclusive, and of all patients who received a
renal transplant during the same period of time. The dialysis
and renal transplant patients were compared with the general
Danish population >18 years of age as of 1 January 2000. For
all the patients and health subjects, the occurrence of aﬁrst frac-
ture event was recorded based on the data available in the Na-
tional Patient Registry, which contains data on events and
treatments of both inpatients and outpatients, so that almost
all types of fractures are recorded, in contrast with most previ-
ous studies, which reported only on hip and other major
fractures.
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The ﬁrst ﬁnding was that dialysis and renal transplant pa-
tients have a 3-fold and 2-fold risk of fractures, respectively,
as compared with healthy subjects. This difference was main-
tained even after adjustment for the main personal and clinical
covariates (age, gender, comorbidities, time on dialysis, etc.). It
is worth noting that the reported rate of fractures was consist-
ently lower than those reported in older studies [1–4, 13] and
closer to the fracture rate reported in the recent data from the
Dialysis Outcomes and Practice Patterns Study, at least as far as
the data referring to the hip fracture rate observed in the Swed-
ish population are concerned [10]. The discrepancy between
the data of more recent studies and those of older ones cannot
be attributed to an underreporting of fractures in the former,
because, as previously underlined, this possibility would have
had an effect on the latter studies. It cannot be excluded, how-
ever, that differences in the ethnic and/or comorbidity charac-
teristics of different cohorts could explain part of these different
results. Another potential explanation may be linked to
improvements in the therapeutic tools for the control of
CKD-MBD. This hypothesis could be indirectly suggested by
some recent studies that showed a trend in a reduction of frac-
ture rates in both dialysis [14] and transplanted patients [15]
during the ﬁrst decade of the present century. However, at
odds with these studies, the data presented by Hensen et al.
in this issue seem to contradict such a hypothesis. In fact,
when three different time periods were compared (2000–
2003, 2004–2007, 2008–2011), the fracture rate remained com-
pletely unchanged in both dialysis and renal transplant patients.
These conﬂicting results raise some old and never answered
questions. First, are the available therapies to correct MM para-
meters also effective on fractures in CKD patients? In the pri-
mary analysis of the results of the most important study
carried out on this topic [16], we realized that, although the
more recent therapeutic tools have been shown to be effective
in the control of MM parameters, this did not translate into
any apparent improvement of fracture occurrence in dialysis pa-
tients. Strictly linked to this question is a second one: are theMM
derangements the true culprits of fractures in CKD? In fact, evi-
dence that MM parameters play a major causal role in such a
clinical complication is scanty and controversial. Some data
seem to suggest that, at least in renal transplant patients, higher
PTH levels might be associated with an increased fracture risk
[17]. On the other hand, the studies dealing with the relationship
between MM parameters and the occurrence of fractures in dia-
lysis patients reported only marginal or no role for PTH and no
effect at all for calcium and phosphorus on the fracture risk [18,
19]. Some studies even reported that low, more than high, PTH
levels were associated with an increased risk of fractures [13, 20].
These data suggest that when we approach the problem of
fracture prevention in CKD, we should take into account other
causal factors, as for the prevention of osteoporotic fractures in
the general population, not strictly related to theMMparameters
that are considered the classic targets of ourmedical intervention
[21]. As yet, we have scanty and largely undeﬁned notions of
what might be the role in CKD patients of drugs already in
use, or proposed to be used, in the general population for pre-
venting the occurrence of fractures, such as bisphosphonates, de-
nosumab, or anti-sclerostin antibodies [21–24].
Missing information common to most published studies
dealing with fracture topics in CKD, including the study from
Hensen et al. in this issue, is related to the underdiagnosis of
‘asymptomatic’ vertebral fractures. In fact, this type of fracture
can be detected only if a systematic radiological assessment of
the thoracic and lumbar spine is performed in each patient ac-
cording to well-deﬁned criteria [25, 26]. Since these fractures
are usually asymptomatic, more than two-thirds of them remain
undiagnosed [27]. However, in our personal data set of CKD pa-
tients explored for asymptomatic vertebral fractures at the time of
renal transplantation, >25% had at least one fracture in one or
more thoracic and/or lumbar vertebrae, with this ﬁgure being
completely similar to that reported in another study [17].
Missing diagnoses of these fractures is of relevance since it
has been demonstrated that asymptomatic vertebral fractures
are associated not only with a greater risk of developing future,
more severe (symptomatic) vertebral fractures, but also with
fracture events in other skeletal sites, an increased risk of
physical and psychological disability, and of morbidity and
death [21, 27].
Summarizing, the paper of Hensen et al. conﬁrms that the
incidence of fractures is higher in CKD patients on renal
replacement therapy.
The community of nephrologists involved in clinical re-
search related to CKD-MBD should devote much more effort
to gaining insights into the following issues:
– To know more precisely the present prevalence and inci-
dence of fractures in the different CKD cohorts
– To assess CKD patients for the presence of ‘asymptomatic’
vertebral fractures
– To clarify if and howmuchMM changes are really involved
in the pathogenesis of skeletal fractures
– To deﬁne if, in CKD patients, there is a place for the use of
drugs already used or proposed to be used in the near future
for fracture prevention in the general population.
Thus we look forward to receiving not only observational
data, but hopefully new randomized controlled trials on these
topics.
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In this issue of Nephrology, Dialysis and Transplantation, Ayus
et al. [1] report on the association between chronic hyponatrae-
mia and the risk of hip fracture in an elderly population. The
authors use a retrospective analysis of data derived from a
health maintenance organization administrative database. The
study includes 31 527 adults, whereby ‘elderly’ is deﬁned as age
>60 years and chronic hyponatraemia as two consecutive mea-
surements of serum sodium <135 mmol/L. Elderly patients
with chronic hyponatraemia had a 4.5 times higher relative
risk for hip fracture.
Whereas this result seems impressive, and is in line with
previous reports describing an association between chronic
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